OMT-111 for Terminal Stage Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Pancreatic Cancer|Lung Cancer
Interventions: DRUG: OMT-111
Sponsor: MetiMedi Pharmaceuticals